Responsible Translational Pathways for Germline Gene Editing?

Area of Science:

• Biotechnology
• Bioethics
• Genetics

Background:

• Gene editing technologies are advancing, making clinical applications of germline gene editing a possibility.
• An unethical experiment in 2018 involving edited embryos highlighted urgent ethical considerations.

Purpose of the Study:

• To examine the ethical issues surrounding translational pathways for human germline gene editing.
• To chart responsible approaches for the clinical application of germline gene editing.

Main Methods:

• Literature review on the development of clinical applications of germline gene editing.
• Analysis of emerging ethical challenges and key issues.

Main Results:

• A growing body of literature addresses clinical applications of germline gene editing.
• Key ethical issues are emerging as significant challenges for responsible translation.

Conclusions:

• Outstanding ethical questions regarding clinical utility, justification, and human subjects research remain.
• Addressing these ethical questions will guide researchers and clinicians toward justifiable applications.